Category: Tools
- CRISPR Therapeutics and ViaCyte, Inc. to Start Clinical Trial of the First Gene-Edited Cell Replacement Therapy for Treatment of Type 1 Diabetes ()
ZUG, Switzerland and CAMBRIDGE, Mass. and SAN DIEGO, Nov. 16, 2021 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ: CRSP), a biopharmaceutical company focused on developing transformative gene-based medicines for serious diseases, and ViaCyte, Inc., a clinical-stage regenerative medicine company developing novel cell replacement therapies to address diseases with significant unmet needs, today announced that Health Canada […]
- CZI Awards Over $5M to Advance Technologies and Expand Global Access to Bioimaging ()
Today, the Chan Zuckerberg Initiative (CZI) announced more than $5 million to advance bioimaging technologies, increase access to these tools, and build capacity for biomedical researchers. Of the funding, $1 million will support 41 plugin projects for the imaging analysis tool napari, while $4.1 million will support 17 projects to increase access to imaging instrumentation […]